Expression of cell-cycle regulatory proteins in endometrial carcinomas: Correlations with hormone receptor status and clinicopathologic parameters

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 9, 2001, Pages 537-544

  Milde Langosch, Karin ^a   Bamberger, Ana Maria ^a   Goemann, Christoph ^a   Rössing, Elena ^a   Rieck, Gabriele ^a   Kelp, Bianca ^a   Löning, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cell cycle; Cyclin B1; Cyclin E; Endometrial carcinoma

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; ESTROGEN RECEPTOR; HORMONE RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P16; PROTEIN P21; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETINOBLASTOMA PROTEIN;

EID: 0034886502     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100256     Document Type: Article

References (34)

1. P53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein
2. Expression pattern of the AP-1 family in breast cancer: Association of fosB expression with a well-differentiated, receptor-positive phenotype
3. Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia
4. Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histological parameters
5. Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation
6. Cell cycle control in mammalian cells: Role of cycling, cyclin-dependent linases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
7. Cyclin E, a redundant cyclin in breast cancer
8. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F
9. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma
10. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma
11. Cell-proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes
12. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions
13. Endometrial carcinoma
14. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma
15. INK4a in breast cancer is associated with a more malignant phenotype
16. P16/MTS1 and pRb expression in endometrial carcinomas
17. Expression of cell-cycle regulatory proteins Rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein-1 family members
18. Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype
19. Principles of CDK regulation
20. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
21. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas
22. INK4a/CDKN2A tumor suppressor and its relatives
23. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis
24. P53: A cell cycle regulator activated by DNA damage
25. Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle
26. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma
27. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implications
28. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells
29. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver
30. The role of pl6-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
31. Regulation of the cyclin B degradation system by an inhibitor of mitotic proteolysis
32. The retinoblastoma protein and cell cycle control
33. INK4B alterations in primary gynecologic malignancies
34. Analysis of the retinoblastoma gene in human endometrial carcinoma